Ubaldo Bonuccelli
Overview
Explore the profile of Ubaldo Bonuccelli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
245
Citations
5880
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Salvadori E, Poggesi A, Pracucci G, Chiti A, Ciolli L, Bene A, et al.
Cereb Circ Cogn Behav
. 2022 Nov;
2:100008.
PMID: 36324712
Objectives: The Montreal Cognitive Assessment (MoCA) is a cognitive screening test largely employed in vascular cognitive impairment, but there are no data about MoCA longitudinal changes in patients with cerebral...
2.
Galgani A, Lombardo F, Martini N, Vergallo A, Bastiani L, Hampel H, et al.
Eur J Neurol
. 2022 Sep;
30(1):32-46.
PMID: 36086917
Background And Purpose: Human neuropathological studies indicate that the pontine nucleus Locus Coeruleus (LC) undergoes significant and early degeneration in Alzheimer's disease. This line of evidence alongside experimental data suggests...
3.
Cammisuli D, Franzoni F, Scarfo G, Fusi J, Gesi M, Bonuccelli U, et al.
Biology (Basel)
. 2022 May;
11(5).
PMID: 35625381
Here we performed a narrative review highlighting the effect of brain/cognitive reserve and natural/synthetic antioxidants in exerting a neuroprotective effect against cognitive deterioration during physiological and pathological aging. Particularly, we...
4.
Palermo G, Giannoni S, Depalo T, Frosini D, Volterrani D, Siciliano G, et al.
Mov Disord Clin Pract
. 2022 May;
9(4):530-534.
PMID: 35582312
Background: Scans without evidence of dopaminergic deficit (SWEDDs) refer to patients clinically diagnosed with Parkinson's disease (PD), but showing normal findings on dopamine transporter single-photon emission computed tomography (DAT-SPECT). This...
5.
Cammisuli D, Cignoni F, Ceravolo R, Bonuccelli U, Castelnuovo G
Front Neurol
. 2022 Feb;
12:798191.
PMID: 35185754
Alzheimer's disease (AD) and Parkinson's disease (PD) are neurodegenerative disorders characterized by cognitive impairment and functional decline increasing with disease progression. Within non-pharmacological interventions, transcranial direct current stimulation (tDCS) might...
6.
Giorgi F, Lombardo F, Galgani A, Hlavata H, Della Latta D, Martini N, et al.
Brain Imaging Behav
. 2021 Nov;
16(3):1077-1087.
PMID: 34741273
The locus coeruleus is the main noradrenergic nucleus of the brain and is often affected in neurodegenerative diseases. Recently, magnetic resonance imaging with specific T1-weighted sequences for neuromelanin has been...
7.
Palermo G, Belli E, Tommasini L, Morganti R, Frosini D, Nicoletti V, et al.
J Alzheimers Dis
. 2021 Oct;
84(2):757-766.
PMID: 34602466
Background: Dementia with Lewy bodies (DLB) and Parkinson's disease dementia (PDD) are differentiated by the time of onset of cognitive and motor symptoms ('1-year rule'). We explored the neuropsychological continuum...
8.
Elefante C, Brancati G, Bacciardi S, Mazzucchi S, Del Prete E, Palermo G, et al.
J Clin Med
. 2021 Jun;
10(11).
PMID: 34070549
Mood and anxiety disorders are the most common neuropsychiatric syndromes associated with Parkinson's disease (PD). The aim of our study was to estimate the prevalence of lifetime and current anxiety...
9.
Solini A, Rossi C, Santini E, Giuntini M, Raggi F, Parolini F, et al.
Eur J Neurol
. 2021 May;
28(8):2648-2656.
PMID: 33991356
Background And Purpose: Neuroinflammation and probably systemic inflammation, with abnormal α-synuclein deposition, participate in the development of Parkinson's disease (PD). The P2X7 receptor/NLRP3 inflammasome complex is upregulated in the brain...
10.
Cammisuli D, Pagni C, Palermo G, Frosini D, Bonaccorsi J, Radicchi C, et al.
Front Psychol
. 2021 Apr;
12:546476.
PMID: 33859587
In the present study, we aimed to better investigate attention system profile of Parkinson's disease-Mild Cognitive Impairment (PD-MCI) patients and to determine if specific attentional deficits are associated with 123I-FP-CIT...